Welcome to CDC stacks |
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
HPV type attribution in high grade cervical lesions in the United States
Filetype[PDF-577.44 KB]


  • Supporting Files:
    No Additional Files
    1. Population-based HPV genotype attribution in HPV-associated cancers, United States
      Personal Author:
      Saraiya, Mona
      Corporate Authors:
      National Center for Chronic Disease Prevention and Health Promotion (U.S.). Division of Cancer Prevention and Control.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      05-Flu-Grohskopf.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 1006.96 KB]
    2. 9-valent HPV (9vHPV) vaccine program key results
      Personal Author:
      Luxembourg, Alain
      Corporate Authors:
      Merck Research Laboratories.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      05-HPV-Markowitz.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 255.99 KB]
    3. Human papillomavirus (HPV) vaccine session
      Personal Author:
      Bocchini, Joseph A.
      Corporate Authors:
      United States. Advisory Committee on Immunization Practices. HPV Vaccines Work Group
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      04-Mening-Patel.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 188.38 KB]
    4. Summary and future ACIP HPV Vaccine Workgroup plans
      Personal Author:
      Markowitz, Lauri E.
      Corporate Authors:
      National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Division of STD Prevention.
      Conference Authors:
      United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
      Published Date:
      February 27, 2014
      Source:
      06-Flu-Cano.pdf
      Series:
      ACIP meeting Human Papillomavirus (HPV) Vaccines Update
      File Type:
      Filetype[PDF - 277.03 KB]
You May Also Like:
  1. Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012☆
    Personal Author:
    Hariri, Susan; Bennett, Nancy M.; Niccolai, Linda M.; Schafer, Sean; Park, Ina U.; Bloch, Karen C.; Unger, Elizabeth R.; Whitney, Erin; Julian, Pamela; Scahill, Mary W.; Abdullah, Nasreen; Levine, Diane; Johnson, Michelle L.; Steinau, Martin; Markowitz, Lauri E.;
    Published Date:
    February 11 2015
    Source:
    Vaccine. 33(13):1608-1613
    Description:
    Background:Prevention of pre-invasive cervical lesions is an important benefit of HPV vaccines, but demonstrating impact on these lesions is impeded by changes in cervical cancer screening. Monitoring vaccine-types associated with lesions can help di...
    File Type:
    Filetype[PDF - 395.96 KB]
  2. Advisory Committee on Immunization Practices (ACIP) summary report : February 26-27, 2014, Atlanta, Georgia
    Corporate Authors:
    United States. Advisory Committee on Immunization Practices.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 February 26-27 : Atlanta, GA)
    Published Date:
    2010
    Series:
    ACIP meeting Minutes
    File Type:
    Filetype[PDF - 1.69 MB]
  3. Human Papillomavirus Genotypes in High-Grade Cervical Lesions in the United States
    Personal Author:
    Hariri, Susan; Unger, Elizabeth R.; Powell, Suzanne E.; Bauer, Heidi M.; Bennett, Nancy M.; Bloch, Karen C.; Niccolai, Linda M.; Schafer, Sean; Steinau, Martin; Markowitz, Lauri E.;
    Corporate Authors:
    HPV-IMPACT Working Group
    Published Date:
    October 08 2012
    Source:
    J Infect Dis. 206(12):1878-1886
    Description:
    Background.Two vaccines protect against human papillomaviruses (HPV) 16 and 18, which cause 70% of cervical cancer and 50% of cervical intraepithelial neoplasia 2/3 and adenocarcinoma in situ (CIN2+). Monitoring HPV types in CIN2+ may be used to asse...
    File Type:
    Filetype[PDF - 646.29 KB]
  4. Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008–2014
    Personal Author:
    McClung, Nancy M.; Gargano, Julia W.; Bennett, Nancy M.; Niccolai, Linda M.; Abdullah, Nasreen; Griffin, Marie R.; Park, Ina U.; Cleveland, Angela A.; Querec, Troy D.; Unger, Elizabeth R.; Markowitz, Lauri E.;
    Corporate Authors:
    HPV-IMPACT Working Group
    Published Date:
    February 21 2019
    Source:
    Cancer Epidemiol Biomarkers Prev. 28(3):602-609
    Description:
    Background:The impact of human papillomavirus (HPV) vaccination has been observed in the United States through declining cervical precancer incidence in young women. To further evaluate vaccine impact, we described trends in HPV vaccine types 16/18 i...
    File Type:
    Filetype[PDF - 531.84 KB]
  5. 9-valent HPV vaccine (9vHPV) GRADE policy questions, available data, PICO
    Personal Author:
    Dunne, Eileen F.
    Conference Authors:
    United States. Advisory Committee on Immunization Practices. Meeting (2014 June 25-26 : Atlanta, GA)
    Published Date:
    June 25, 2014
    Series:
    ACIP meeting Human Papillomavirus (HPV) Vaccines Update
    File Type:
    Filetype[PDF - 224.97 KB]